A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer
Clinical trial NCT06692166 · RECRUITING
Trial details
- NCT number
- NCT06692166
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-10
- Primary completion
- 2027-12-09
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.